home / stock / imcr / imcr articles

IMCR Articles, Immunocore Holdings plc

Stock Information
Company Name: Immunocore Holdings plc
Stock Symbol: IMCR
Market: NASDAQ
Website: immunocore.com
Menu
IMCR IMCR Quote IMCR Short IMCR News IMCR Articles IMCR Message Board
Get IMCR Alerts

News, Short Squeeze, Breakout and More Instantly...
Why Science Applications International Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Monday's Mid-Day Session | Benzinga

Shares of Science Applications International Corporation (NASDAQ:SAIC) declined 11% to $119.91 following first-quarter results. SAIC reported a 9% ...
Why NetEase Shares Are Trading Lower? Here Are Other Stocks Moving In Friday's Mid-Day Session | Benzinga

Shares of NetEase, Inc. (NASDAQ:NTES) fell during Friday's session after the company reported worse-than-expected first-quarter revenue. NetEa...

Immunocore announces clinical trial collaboration and supply agreement with Bristol Myers Squibb to evaluate IMC-F106C (PRAME HLA-A02) in combination with nivolumab in its registrational Phase 3 first-line advanced cutaneous melanoma trial | Benzinga

Immunocore announces clinical trial collaboration and supply agreement with Bristol Myers Squibb to evaluate IMC-F106C (PRAME HLA-A02) in combinat...

Immunocore's Pipeline Is Among The Strongest In Broader Biotech Universe: Analyst | Benzinga

H.C. Wainwright analyst Patrick R. Trucchio reiterated a Buy rating on Immunocore Holdings Plc (NASDAQ: IMCR) with a price targ...
Why Applied Therapeutics Shares Are Trading Lower By Over 35%? Here Are Other Stocks Moving In Friday's Mid-Day Session | Benzinga

Shares of Applied Therapeutics, Inc. (NASDAQ: APLT) shares fell sharply during Friday’s session after the company released topline results ...

Levicept Appoints Eliot Forster as CEO | Benzinga

Leadership Team Strengthened as Clinical Development of LEVI-04 a Novel Neurotrophin Modulator for Osteoarthritis and Chronic Pain Advances SANDWI...

Cancer Focused Immunocore Leads The Way In TCR Therapeutics, Positioned For Success: Analyst Says | Benzinga

Needham has initiated coverage on Immunocore Holdings Plc (NASDAQ: IMCR) with a Buy rating and a price target of $75. Needham a...
Immunocore to present at upcoming investor conferences | Benzinga

Immunocore to present at upcoming investor conferences (OXFORDSHIRE, England & CONSHOHOCKEN, Penn. & ROCKVILLE, Md., US, 01 September 2023...

Next 10